Komarovsky: vaccines are likely to reduce their effectiveness against the omicron-strain 
Doctor and TV presenter Yevgeny Komarovsky »Collected the main information about the omicron-strain of coronavirus. The physician urged citizens to wait for the results of research on the new strain, and also gave a forecast on the effectiveness of the available vaccines against this mutation.
“Today we can say one thing for sure: PCR tests that detect delta, alpha and other [strains] can also detect the omicron strain. As of today, there are no real, precise answers to any [other] question, “Komarovsky said. The doctor explained that at the moment the relevant studies are already underway.
Answers to questions about vaccines will be known in a week and a half, the TV presenter believes. In another month or a month and a half, information should be received about the infectivity in comparison with earlier mutations, the ability of the variant to infect vaccinated and unvaccinated, the real severity of the disease and the presence of additional symptoms.
However, the most pressing issue, according to Komarovsky, is the effectiveness of vaccines against this mutation. Despite the fact that the exact answer has not yet been given, many scientists, whose opinion the TV presenter is inclined to trust, believe that most likely the main vaccines today will reduce their effectiveness by several percent, but will retain the main result. “Vaccines will continue to prevent not a symptomatic disease, but a severe form of the disease, that is, vaccines will continue to protect against resuscitation. Therefore, we continue to vaccinate. This is extremely important, “the doctor concluded.
Earlier, the doctor and TV presenter Alexander Myasnikov called revaccination the only way to protect against the omicron strain of coronavirus. According to the specialist, it is likely that the vaccines will need to be adjusted. The doctor added that any subsequent mutation of the coronavirus infection will be more infectious than the previous one, and this development of events is normal for the evolution of the virus. However, he does not exclude the possibility that the new variants of COVID-19 will be more easily tolerated than the delta strain.